Neurofilament makes light of MS treatment monitoring
- PMID: 30804512
- DOI: 10.1038/s41582-019-0156-6
Neurofilament makes light of MS treatment monitoring
Comment on
-
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.Neurology. 2019 Mar 5;92(10):e1007-e1015. doi: 10.1212/WNL.0000000000007032. Epub 2019 Feb 8. Neurology. 2019. PMID: 30737333 Free PMC article. Clinical Trial.
References
Original articles
-
- Kuhle, J. et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology https://doi.org/10.1212/WNL.0000000000007032 (2019) - DOI - PubMed
-
- Dalla Costa, G. et al. Serum neurofilaments increase at PML onset in natalizumab-treated MS patients. Ann. Neurol. https://doi.org/10.1002/ana.25437 (2019) - DOI - PubMed
Further reading
-
- Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577–589 (2018) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
